World Cord Blood Society –

HONG KONG, June 16, 2022 /PRNewswire/ — Global Cord Blood Corporation (NYSE: CO, “GCBC” or the “Company”), China leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, noted that on June 3, 2022 Blue Ocean Structure Investment Company Limited (the “Applicant”) has issued a notice to convene an Extraordinary General Meeting of the Company (“the so-called EGM”) to be held on June 16, 2022.

The Company’s position is that this EGM was not validly convened. The so-called EGM was convened without the required threshold of 75% having been reached.

The Company considers it inappropriate to comment on the matters presented for the so-called EGM at this stage. These issues are currently being debated live at the Cayman Islands and the British Virgin Islands.

The Company looks forward to providing investors with an update as soon as appropriate.

About Global Cord Blood Corporation

Global Cord Blood Corporation is an umbilical cord blood bank operator serving several regions of the China. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the company’s website at: .

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the future financial performance of the Company. The Company has attempted to identify forward-looking statements by terminology including “anticipates”, “believes”, “expects”, “may”, “continues”, “could”, “estimates”, “intends of”, “may”, “plans”, “potential”, “predict”, “should” or “will” or the negative form of these terms or any other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the actual results, levels of activity, performance or achievements of the Company to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. information contained in this press release is not intended to project the future performance of the Company.While the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee the results, levels of activity, pe future rformances or achievements. The Company’s expectations are as of the date of this press release, and the Company does not intend to update any forward-looking statements after the date of this press release to conform such statements to results. real, except as required by law.

View original content:

SOURCE Global Cord Blood Corporation

Luisa D. Fuller